Mark Jackson

Mark Jackson has extensive experience in intellectual property, particularly in the field of biotechnology. Mark joined Genentech in 1980 and held the position of Senior Patent Counsel | Patent Counsel for over three decades. In this role, they played a key role in directing global patent litigation activities, overseeing a team and coordinating efforts with external legal firms. Mark's expertise contributed to the successful resolution of over 90% of cases, while also considering financial responsibilities and long-term business strategies. In 2015, Mark joined Editas Medicine as Director of Intellectual Property, later being promoted to Senior Director and then Vice President in 2020.

Mark Jackson has a Juris Doctor (J.D.) degree from Golden Gate University and a Bachelor's degree in Zoology from the University of California, Berkeley.